Pharmacogenomics of statins: lipid response and other outcomes in Brazilian cohorts (2022)
- Authors:
- USP affiliated authors: HIRATA, MARIO HIROYUKI - FCF ; HIRATA, ROSARIO DOMINGUEZ CRESPO - FCF ; HERNANDEZ, CAROLINA DAGLI - FCF ; HIRATA, THIAGO DOMINGUEZ CRESPO - FCF
- Unidade: FCF
- DOI: 10.1007/s43440-021-00319-y
- Subjects: ESTATINAS; FARMACOGENÉTICA
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: Heidelberg
- Date published: 2022
- Source:
- Título do periódico: Pharmacological Reports
- ISSN: 1734-1140
- Volume/Número/Paginação/Ano: v. 74, p. 47–66, 2022
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
HERNANDEZ, Carolina Dagli et al. Pharmacogenomics of statins: lipid response and other outcomes in Brazilian cohorts. Pharmacological Reports, v. 74, p. 47–66, 2022Tradução . . Disponível em: https://doi.org/10.1007/s43440-021-00319-y. Acesso em: 29 mar. 2024. -
APA
Hernandez, C. D., Zhou, Y., Lauschke, V. M., Genvigir, F. D. V., Hirata, T. D. C., Hirata, M. H., & Hirata, R. D. C. (2022). Pharmacogenomics of statins: lipid response and other outcomes in Brazilian cohorts. Pharmacological Reports, 74, 47–66. doi:10.1007/s43440-021-00319-y -
NLM
Hernandez CD, Zhou Y, Lauschke VM, Genvigir FDV, Hirata TDC, Hirata MH, Hirata RDC. Pharmacogenomics of statins: lipid response and other outcomes in Brazilian cohorts [Internet]. Pharmacological Reports. 2022 ; 74 47–66.[citado 2024 mar. 29 ] Available from: https://doi.org/10.1007/s43440-021-00319-y -
Vancouver
Hernandez CD, Zhou Y, Lauschke VM, Genvigir FDV, Hirata TDC, Hirata MH, Hirata RDC. Pharmacogenomics of statins: lipid response and other outcomes in Brazilian cohorts [Internet]. Pharmacological Reports. 2022 ; 74 47–66.[citado 2024 mar. 29 ] Available from: https://doi.org/10.1007/s43440-021-00319-y - Cardiovascular pharmacogenomics: an update on clinical studies of antithrombotic drugs in Brazilian patients
- Mycophenolic acid pharmacogenomics in kidney transplantation
- Pharmacogenomics of mycophenolic acid in kidney transplantation: Contribution of immune response-related genes
- Increased levels of plasma IL-1b and BDNF can predict resistant depression patients
- Proposta de medicina personalizada utilizando perfil farmacogenético em pacientes idosos usuários de varfarina
- High serum miR-421 is associated with metabolic dysregulation and inflammation in patients with metabolic syndrome
- Could SNPs predict Cisplatin toxicity?
- Validation of TREML4 mRNA expression and polymorphisms in blood leukocytes as potential biomarker of atherosclerosis
- Bases farmacogenômicas da resistência medicamentosa
- Inclusion body formation in escherichia coli: a procedure for optimizing production of soluble protein in application to human interferon alpha receptor
Informações sobre o DOI: 10.1007/s43440-021-00319-y (Fonte: oaDOI API)
Download do texto completo
Tipo | Nome | Link | |
---|---|---|---|
3042588.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas